Chemo-immunotherapy approach shows potential benefit in advanced HPV-negative head-and-neck cancer. Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus-negative head-and-neck squamous cell carcinoma. More than half of study participants had 50% or more of their tumors shrink after receiving the immunotherapy drug nivolumab with chemotherapy, followed by response-adaptive chemo-radiation therapy.? https://lnkd.in/e7bc5y4i
The Cancer Letter
报纸出版业
Washington，District of Columbia 2,720 位关注者
The leading independent source for information on the issues that shape oncology since 1973.
关于我们
The Cancer Letter, an independent weekly news publication, has been the leading source for information on the issues that shape oncology since 1973. The Cancer Letter provides authoritative, award-winning coverage of the development of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health. Our coverage focuses on the National Cancer Institute, National Institutes of Health, Food & Drug Administration, U.S. Congress, cancer centers, and the pharmaceutical industry. The Cancer Letter’s readers include key opinion leaders at academic institutions, community oncology practices, government agencies, professional associations, health IT and pharmaceutical companies, Wall Street, and advocacy organizations. Based in Washington, D.C., The Cancer Letter has earned acclaim for its investigative work. It has been profiled and cited in outlets including The New York Times, The Washington Post, 60 Minutes, CNN, NPR, Science, and Nature. Coverage by The Cancer Letter has triggered multiple investigations by Congressional committees, the Institute of Medicine, the Federal Trade Commission, the Securities and Exchange Commission, and the Department of Justice, and contributed to federal action by the FDA, the Centers for Disease Control and Prevention, the Federal Bureau of Investigation, and Government Accountability Office.
- 网站
-
https://cancerletter.com
The Cancer Letter的外部链接
- 所属行业
- 报纸出版业
- 规模
- 2-10 人
- 总部
- Washington，District of Columbia
- 类型
- 私人持股
- 创立
- 1973
- 领域
- Oncology、Journalism和Cancer
地点
-
主要
获取路线
The Cancer Letter Inc.
US，District of Columbia，Washington，20016
The Cancer Letter员工
动态
-
Tari King appointed chief surgical officer for cancer service line, co-director of Glenn Family Breast Center at Winship Cancer Institute of Emory University, chief of Division of Breast Surgery at Emory https://lnkd.in/eKjKwfpD
-
-
In support of three coordinated CCSG components reducing our national burden of cancer. Guest editorial by Shine Chang, PhD (MD Anderson Cancer Center), Michaela Dinan, PhD (Yale Cancer Center), and Miria Kano, PhD (University of Colorado Cancer Center) https://lnkd.in/eJ6VTDJP
-
-
Florida leukemia rates rising rapidly as population ages, Sylvester Comprehensive Cancer Center study shows. Driven by a steady influx of retirees, Florida now has the highest leukemia rates of any U.S. state and the disease is the fastest-rising cancer type statewide. https://lnkd.in/gHFWD8gy
-
This week in the headlines: Could “flooding the zone” drown NIH and cancer centers? With a growing backlog at NIH and Columbia University’s grants getting canceled over alleged antisemitism, where does that leave NCI-designated cancer centers? Paul Goldberg, editor and publisher of?The Cancer Letter, and Claire Marie Porter, reporter, discuss this and more on the latest episode of The Cancer Letter Podcast. https://lnkd.in/efHcNBUu
-
Kathy Giusti joins Thyme Care as strategic advisor for patient experience https://lnkd.in/ePX5nRzF
-
-
FDA grants Orphan Drug designation to rhenium obisbemeda for leptomeningeal metastases in lung cancer https://lnkd.in/gACQ7qRM
-
Accelerating translational research in leukemia: The City of Hope approach Guest editorial by Guido Marcucci "One of the most promising developments in leukemia research is the increasing ability to personalize therapy. Advances in sequencing technology now enable whole-genome sequencing of leukemia cells within 48 hours—a remarkable leap forward from the decade it once took to complete the first human genome sequence." #Leukemia https://lnkd.in/eGisr9QK
-
Rathmell: My mentor recognized a cliff I was going to fall off before I did. Guest editorial by W. Kimryn Rathmell, MD, PhD, MMHC https://lnkd.in/eC3MB6XT
-
-
American College of Radiology to form early lung cancer detection registry https://lnkd.in/ezninKBY